| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jul―11 |
Targeted IL-27-based gene therapy in preventing SARS-CoV-2 entry |
Grace E. Mulia, Janelle E. Salameh, Marxa L. Figueiredo |
| 2 |
[GO] |
2026―Jun―23 |
Genomic surveillance of SARS-CoV-2: a resource-efficient wastewater-based workflow |
Julieta M. Manrique, Leandro R. Jones |
| 3 |
[GO] |
2026―Jun―03 |
Increased Carbapenem resistance and gene carriage in Pseudomonas aeruginosa clinical isolates after the COVID-19 pandemic in Egypt |
Soha S. Abdelrahim, Shaimaa Zaki, Dalia N. Kotb |
| 4 |
[GO] |
2026―Mai―09 |
Host mitochondrial apoptotic signatures in children with chronic conditions reveal viral modulation of MCL-1 in severe SARS-CoV-2 infection |
Emilly Henrique dos Santos, Gabriel Acca Barreira, Mariana Okay Saippa, Lucas Augusto Moysés Franco, Mussya Cisotto Rocha, Kelly Aparecida Kanunfre, Maria Fernanda Badue Pereira, Heloisa Helena Sousa Marques, Thelma Suely Okay |
| 5 |
[GO] |
2026―Apr―25 |
Inhibition of SARS-CoV-2 spike S1-ACE2 binding interaction and downregulation of ACE2 gene expression by Malaysian stingless bee honey and its bioactive compound, stilbamidine (SDC) |
Che Muhammad Khairul Hisyam Ismail, Azlini Ismail, Mohd Ridzuan Mohd Abd Razak, Azzmer Azzar Abdul Hamid, Khairani Idah Mokhtar, Widya Lestari, Basma Ezzat Mustafa Alahmad |
| 6 |
[GO] |
2026―Apr―11 |
COVID-19 vaccination shifts neutrophils toward a mixed activated and regulatory phenotype in patients with severe disease |
Yrna Lorena M. de Oliveira, Ayane de S. Resende, Mariana N. F. de Franca, Camilla Natália O. Santos, Lucas S. Magalhães, Cristiane B. Correa, Priscila L. dos S. Almeida, Angela Maria da Silva, Michael W. Lipscomb, Tatiana R. de Moura |
| 7 |
[GO] |
2026―Apr―03 |
Reduction of virus isolation effectiveness from throat swab double positive to H1N1pdm09 and H3N2 influenza A virus strain with SARS-CoV-2 virus in cell cultures |
Rosaria Arvia, Valentina Tassone, Simone Giannecchini |
| 8 |
[GO] |
2026―Feb―19 |
Long COVID-associated neurological symptoms and brain fog: Understanding the mechanism of neuroinflammation, BBB disruption, diagnostics, and therapeutics |
Chiranjib Chakraborty, Manojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee |
| 9 |
[GO] |
2025―Dez―10 |
Improving directed evolution strategies: error-prone PCR optimization for SARS-CoV-2 spike receptor binding domain |
Tanay Uzgan, Bianca Schulte, Husniye Tansel Yalcin |
| 10 |
[GO] |
2025―Nov―24 |
Comparative viral load analysis of torque Teno virus and Torque teno mini virus in COVID-19 infected and non-infected individuals in the United Arab Emirates |
Gayathri Arumughan Kanu, Raed Abu Odeh, Zamberi Sekawi, Zulkefley Othman |
| 11 |
[GO] |
2025―Nov―05 |
The impact of TMPRSS11A rs353163 and rs977728 polymorphisms on COVID-19 severity: genotypic and clinical associations |
Nilgun Cekin, Seyda Akin, Ergun Pinarbasi, Halef Okan Dogan |
| 12 |
[GO] |
2025―Okt―14 |
Spatiotemporal and demographic patterns of SARS-CoV-2 entry gene expression in a Lebanese cohort |
Fatima Al Nemer, Mohammad Fayyad-Kazan, Bassam Badran, Nada Borghol |
| 13 |
[GO] |
2025―Okt―11 |
Validation of a dual-purpose conventional PCR strategy for SARS-CoV-2 detection and lineage screening in resource-limited laboratories |
Liliana Iñiguez-Gutiérrez, María Teresa Magaña-Torres, José Daniel Ruiz-Carrillo, Luz Alicia González-Hernández, Jaime Federico Andrade-Villanueva, Brenda Marely Ruelas-Abarca, Ivonne Montserrat Lara-López, Teresita de Jesús Hernández-Flores |
| 14 |
[GO] |
2025―Sep―10 |
Emerging SARS-CoV-2 variants: genomic shifts, immune evasion, and therapeutic perspectives |
Racha Wehbe, Nour Khoshman, Zahraa Ousseily, Sarah Ayad Al-Tameemi, Rania El Majzoub, Mehdi Najar, Makram Merimi, Hussein Fayyad-Kazan, Bassam Badran, Mohammad Fayyad-Kazan |
| 15 |
[GO] |
2025―Jul―18 |
Deciphering TLR and JAK/STAT pathways: genetic variants and targeted therapies in COVID-19 |
Meriem El Houdi, Hanaa Skhoun, Aya Guennoun, Nadia Dakka, Rabii Ameziane El Hassani, Zohra Ouzzif, Jamila El Baghdadi |
| 16 |
[GO] |
2025―Jul―10 |
Correction: Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2 |
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu |
| 17 |
[GO] |
2025―Jun―23 |
The monomeric but not homotrimeric spike protein of SARS-CoV-2 activates TLR4 signaling |
Charlotte Lübow, Günther Weindl |
| 18 |
[GO] |
2025―Jun―23 |
Comparison of factors contributing to drug resistance and infection severity in Pseudomonas aeruginosa isolates among COVID-19 and non-COVID-19 patients |
Haniyeh Norouzi, Hengameh Zandi, Farzan Madadizadeh, Hamid Heidari |
| 19 |
[GO] |
2025―Mai―22 |
SARS-CoV-2 accessory proteins ORF3a and ORF6 alter the miRNome of human lung epithelial cells |
Atul Kumar, Sankha Shubhra Chakrabarti, Sunit Kumar Singh |
| 20 |
[GO] |
2025―Mai―21 |
Exploring the role of mitochondrial dysfunction and aging in COVID-19-Related neurological complications |
Prajakta Hingole, Priya Saha, Sourav Das, Chayanika Gundu, Ashutosh Kumar |
| 21 |
[GO] |
2025―Mai―06 |
Screening the Pandemic Response Box identifies novel ligands of the Staphylococcus aureus protein arginine kinase, McsB |
Ryan Chetty, Alexandré Delport, Sandile Mthembu, Clinton G. L. Veale, Raymond Hewer |
| 22 |
[GO] |
2025―Apr―23 |
Investigating the relationship between the IL-17 rs2275913, IL-17 rs763780, and the IL-6 rs1800795 genotypes in HIV-positive patients with COVID-19 |
Maryam Nejabat, Mohammad Motamedifar, Ava Hashempour, Mohammadreza Heydari, Zohre Foroozanfar, Mohammad Ali Davarpanah, Gholamreza Daryabor |
| 23 |
[GO] |
2025―Mrz―19 |
Association of VDR and TMPRSS2 gene polymorphisms with COVID-19 severity: a computational and clinical study |
Shrikant Verma, Sushma Verma, Zeba Siddiqi, Syed Tasleem Raza, Tabrez Faruqui, Asma Imran Ansari, Mohammad Abbas, Farzana Mahdi |
| 24 |
[GO] |
2025―Mrz―17 |
Role of furin in the severity of COVID-19 infection via effects on miR-20b and miR-106a |
Ismail Mahmoud, Amr E. Ahmed, Olfat Shaker |
| 25 |
[GO] |
2025―Jan―31 |
Upregulation of the MAP2K4 gene triggers endothelial-mesenchymal transition in COVID-19 |
Esra Yilmaz, Dilek Yilmaz, Can Gokay Yildiz, Ercan Cacan |
| 26 |
[GO] |
2025―Jan―08 |
The first assessment of Angiotensin-Converting Enzyme 1 (ACE1) D/I polymorphism and demographic factors in association with COVID-19 outcomes in the Moroccan Population |
Ihssane El Bouchikhi, Ihsane El Otmani, Mohamed Ahakoud, Oussama Kettani, Badreddine El Makhzen, Ghita Yahyaoui, Bouchra Oumokhtar, Karim Ouldim, Mohammed El-Azami-El-Idrissi, Sanae Achour, Mustapha Mahmoud, Laila Bouguenouch |
| 27 |
[GO] |
2024―Okt―28 |
Characterization of the viral genome of Omicron variants of SARS-CoV-2 circulating in Tripura, a remote frontier state in Northeastern India |
Ankan Chakrabarti, Saikat Majumder, Apurba Sarkar, Tapan Majumdar |
| 28 |
[GO] |
2024―Okt―21 |
Potential hypothesis for the increased risk of Parkinson´s disease following COVID-19 |
Raffaella Mormile, Cristina Mormile, Carmine Picone |
| 29 |
[GO] |
2024―Aug―27 |
COVID-19 increases mortality in hemodialysis patients: exploring links with inflammation and telomere attrition |
Tamara Milosevic, Radomir Naumovic, Miron Sopic, Jelena Vekic, Azra Guzonjic, Snezana Pesic, Milica Miljkovic-Trailovic, Jelena Kotur-Stevuljevic |
| 30 |
[GO] |
2024―Aug―08 |
Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS |
Muhammad Atif, Abdullah Alsrhani, Farrah Naz, Sajjad Ullah, Abualgasim Elgaili Abdalla, Muhammad Ikram Ullah, Bi Bi Zainab Mazhari, Lienda Bashier Eltayeb, Ismail Hamad, Hasan Ejaz |
| 31 |
[GO] |
2024―Aug―07 |
Development of highly adaptable RT-PCR methods for identifying Delta and BA.1 variants in inactivated COVID-19 vaccines |
Zhanhui Wang, Yao He, Zhenyu He, Yancen Guo, Yuxiu Zhao, Yuntao Zhang |
| 32 |
[GO] |
2024―Jul―25 |
Cycle threshold (Ct)values of SARS-CoV2 vary with the type of symptoms and comorbidities of the patients |
Naila Shoaib, Rimsha Munir |
| 33 |
[GO] |
2024―Jul―23 |
The study of single nucleotide polymorphism in a promoter region of ACE-2 receptor gene in the samples of Iraqi population with COVID-19 |
Ali H. Mahmood, Salwa J. Al-Awadi, Noora A. Hadi, Marwa M. Al-Attar |
| 34 |
[GO] |
2024―Jul―15 |
The relationship between Nuclear Factor-Kappa B and Inhibitor-Kappa B parameters with clinical course in COVID-19 patients |
Melek Karasu, Muhdi Cevik, Serap Biberoglu, Emine Selva Kaplanoglu, Nilgun Cetinkaya, Dildar Konukoglu, Mine Kucur |
| 35 |
[GO] |
2024―Mai―25 |
Alternations in miR-155 and miR-200 serum levels can serve as biomarkers for COVID-19 in the post-mass vaccination era |
Aliaa Aboulela, Mona Taha, Abeer Ghazal, Ayman Baess, Amel Elsheredy |
| 36 |
[GO] |
2024―Mai―22 |
Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19 |
Muinah Adenike Fowora, Adenike Aiyedogbon, Ibilola Omolopo, Ahmed Oluwasegun Tajudeen, Faustina Onyeaghasiri, Idowu Edu-Muyideen, Abdul-Lateef Olatunde Olanlege, Aminah Abioye, Tajudeen Akanji Bamidele, Toyosi Raheem, Adesegun Adesesan, Bamidele Iwalokun, Babatunde Lawal Salako |
| 37 |
[GO] |
2024―Mai―08 |
Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia |
Valeriy Pokhylko, Yuliia Cherniavska, Liliia Fishchuk, Zoia Rossokha, Olena Popova, Viktoriia Vershyhora, Olena Ievseienkova, Halyna Soloviova, Liudmyla Zhuk, Nataliia Gorovenko |
| 38 |
[GO] |
2024―Apr―25 |
Correction: Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE |
Kevin Maafu Juma, Kenta Morimoto, Vishnu Sharma, Kirti Sharma, Radhika Biyani, Manish Biyani, Teisuke Takita, Kiyoshi Yasukawa |
| 39 |
[GO] |
2024―Feb―24 |
Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection |
Carolyn Krause, Eva Bergmann, Susanne Viktoria Schmidt |
| 40 |
[GO] |
2024―Feb―22 |
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage |
Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf |
| 41 |
[GO] |
2024―Feb―20 |
Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection |
Yousef Rasmi, Ighli di Bari, Shah Faisal, Munima Haque, Pornanong Aramwit, Aline da Silva, Elmira Roshani Asl |
| 42 |
[GO] |
2024―Feb―10 |
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal? |
Ramiar Kamal Kheder, Omeed Darweesh, Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abbas Basiri, Mohammad Taheri |
| 43 |
[GO] |
2024―Feb―08 |
Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE |
Kevin Maafu Juma, Kenta Morimoto, Vishnu Sharma, Kirti Sharma, Radhika Biyani, Manish Biyani, Teisuke Takita, Kiyoshi Yasukawa |
| 44 |
[GO] |
2024―Jan―25 |
Evidence of SARS-CoV-2 infection in companion animals from owners who tested positive for COVID-19 in the Valley of Mexico |
Edith A. Fernández-Figueroa, Deborah V. Espinosa-Martínez, Haydee Miranda-Ortiz, Erika Ruiz-García, Juan M. Figueroa-Esquivel, Miriam L. Becerril-Moctezuma, Anallely Muñoz-Rivas, César A. Ríos-Muñoz |
| 45 |
[GO] |
2024―Jan―22 |
ACE I/D polymorphism is a risk factor for the clinical severity of COVID-19 in Brazilian male patients |
Sandro Soares Almeida, Marcos Fernandes Gregnani, Isabela Moreira Gontijo da Costa, Matheus Matias da Silva, Carolina Bonet Bub, Valmir Oliveira Silvino, Delio Eulalio Martins, Marcelo Wajchenberg |
| 46 |
[GO] |
2024―Jan―06 |
MBOAT7 expression is associated with disease progression in COVID-19 patients |
Eman Radwan, Ahmed Abdelaziz, Manal A. M. Mandour, Abdel-Raheim M. A. Meki, Maha M. El-kholy, Marwan N. Mohamed |
| 47 |
[GO] |
2023―Nov―07 |
Prognostic potential of circulating cell free mitochondrial DNA levels in COVID-19 patients |
Ata Mahmoodpoor, Mojtaba Mohammadzadeh, Rogayyeh Asghari, Majid Tagizadeh, Afshin Iranpour, Mansour Rezayi, Aynour Jalali Pahnvar, Babak Emamalizadeh, Nasim Sohrabifar, Somayeh Kazeminasab |
| 48 |
[GO] |
2023―Nov―02 |
Correction to: association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients |
Samaneh Ramezani, Fatemeh Ezzatifar, Tahereh Hojjatipour, Maryam Hemmatzadeh, Arezoo Gowhari Shabgah, Jamshid Gholizadeh Navashenaq, Saeed Aslani, Navid Shomali, Mohsen Arabi, Farhad Babaie, Farhad Jadidi-Niaragh, Ramin Hosseinzadeh, Fahimeh Feizisani, Sara Khodayar, Roghaiyeh Safari, Hamed Mohammadi |
| 49 |
[GO] |
2023―Okt―29 |
Endangered shark species traded as “cação” in São Paulo during the COVID-19 lockdown: DNA-barcoding a snapshot of products |
Veronica Zuccolo, Fernanda Moreira Rego, Emily Hughes, Andrew M. Griffiths |
| 50 |
[GO] |
2023―Okt―24 |
Assessing the gene expression of the adenosine 5′-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients |
Shirin Assar, Mohammad Dastbaz, Komail Amini, Seyed Askar Roghani, Ramin Lotfi, Mahdi Taghadosi, Hamidreza Kafi, Zahra Abdan, Hosna Allahyari, Rezvan Rostampour, Seyedeh Zahra Shahrokhvand |
| 51 |
[GO] |
2023―Okt―10 |
Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences |
Camila Salazar-Ardiles, Leyla Asserella-Rebollo, Carlos Cornejo, Dayana Arias, Manuel Vasquez-Muñoz, Camilo Toledo, David C. Andrade |
| 52 |
[GO] |
2023―Okt―10 |
Altered expression levels of TAS1R2 and TAS1R3 genes among SARS-CoV-2 variants of concerns |
Qendresa Hoti, Gokce Akan, Gulten Tuncel, Emine Unal Evren, Hakan Evren, Kaya Suer, Tamer Sanlidag, Mahmut Cerkez Ergoren |
| 53 |
[GO] |
2023―Sep―23 |
Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells |
Ladan Dawoody Nejad, Lisa Marie Julian |
| 54 |
[GO] |
2023―Aug―29 |
Assessment of thermal and temporal stability of SARS-CoV-2 samples using real-time qRT-PCR |
Rohit Kumar Swain, S. S. Mohanty, Mahendra Thakor, A. K. Sharma |
| 55 |
[GO] |
2023―Jul―08 |
Genetic variability of rice stripe virus after its pandemic in Jiangsu |
Chengye Lu, Qian Miu, Daoran Jin, Aiguo Li, Zhaobang Cheng, Yijun Zhou, Yunyue Wang, Shuo Li |
| 56 |
[GO] |
2023―Jul―07 |
Histological and molecular response of oral cavity tissues to Covid-19 |
Nehad M. Abd-elmonsif, Sherif Gamal |
| 57 |
[GO] |
2023―Jun―27 |
Association between angiotensin-converting enzyme-2 gene polymorphism (rs2106809) with severity and outcome of COVID-19 infection |
Hamideh Mohammadi-Berenjestanaki, Elaheh Mohammadali, Mina Khasayesi, Alireza Rafiei, Zahra Kashi, Narges Mirzaei-Ilali, Zahra Hosseini-khah |
| 58 |
[GO] |
2023―Jun―08 |
Synergistic effect of elevated glucose levels with SARS-CoV-2 spike protein induced NOX-dependent ROS production in endothelial cells |
Jiahao Zhang, Li He, Rong Huang, Juan Felipe Alvarez, David H. Yang, Qihao Sun, Fengqin Wang, Zhiyong Peng, Nanhui Jiang, Lianjiu Su |
| 59 |
[GO] |
2023―Mai―25 |
Association between mannose binding lectin gene polymorphisms and clinical severity of COVID-19 in children |
Dilek Yilmaz, Mustafa Soyoz, Aslıhan Sahin, Burcu Cerci-Alkac, Hatice Ilayhan Karahan-Coven, Yıldız Ekemen-Keles, Gulnihan Ustundag, Ahu Kara-Aksay, Nisel Yilmaz, İbrahim Pirim |
| 60 |
[GO] |
2023―Mai―24 |
Angiotensin converting enzyme 2 gene expression and markers of oxidative stress are correlated with disease severity in patients with COVID-19 |
Afraa S. H. Alobaidy, Mona Elhelaly, Maggie E. Amer, Rasha S. Shemies, Azza I. Othman, Mohamed A. El-Missiry |
| 61 |
[GO] |
2023―Apr―29 |
Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome |
Peshnyar M.A. Rashid, Gaza F. Salih |
| 62 |
[GO] |
2023―Mrz―15 |
Genetic analysis of ACE2 peptidase domain in SARS-CoV-2-positive and SARS-CoV-2-negative individuals from Pakistan |
Noor Muhammad, Humaira Naeemi, Ayesha Azeem, Rida Sadaqat, Umara Shehzad, Kashif Siddique, Usman Hassan, Aun Raza, Muhammad Usman Rashid |
| 63 |
[GO] |
2023―Jan―28 |
Evaluation of both expression and serum protein levels of caspase-8 and mitogen-activated protein kinase 1 genes in patients with different severities of COVID-19 infection |
Murat Acat, Pınar Yıldız Gülhan, Recep Eröz, Ayşegül Ertınmaz Özkan, Oğuzhan Koca, Caner Çınar |
| 64 |
[GO] |
2023―Jan―05 |
Association between iron metabolism and SARS-COV-2 infection, determined by ferritin, hephaestin and hypoxia-induced factor-1 alpha levels in COVID-19 patients |
Elif Sibel Aslan, Hüseyin Aydın, Yusuf Kenan Tekin, Sami Keleş, Kenneth N. White, Nezih Hekim |
| 65 |
[GO] |
2022―Dez―27 |
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2 |
Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Dabing Li, Xiaoyan Liu, Tao He, Jingliang Cheng, Junjiang Fu |
| 66 |
[GO] |
2022―Dez―23 |
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective |
Subhomoi Borkotoky, Debajit Dey, Zaved Hazarika |
| 67 |
[GO] |
2022―Dez―20 |
Therapeutic role of mTOR inhibitors in control of SARS-CoV-2 viral replication |
Tuba Khalid, Adria Hasan, Jamal e Fatima, Soban Ahmad Faridi, Ahamad Faiz Khan, Snober S. Mir |
| 68 |
[GO] |
2022―Dez―19 |
Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2 |
Vishal Khandelwal, Tarubala Sharma, Saurabh Gupta, Shoorvir Singh, Manish Kumar Sharma, Deepak Parashar, Vivek K. Kashyap |
| 69 |
[GO] |
2022―Dez―07 |
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic |
Fabian Sehn, Hartwig Büttner, Beate Godau, Marten Müller, Semih Sarcan, Anne Offermann, Sven Perner, Mario W. Kramer, Axel S. Merseburger, Marie C. Roesch |
| 70 |
[GO] |
2022―Nov―01 |
Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients |
Samaneh Ramezani, Fatemeh Ezzatifar, Tahereh Hojjatipour, Maryam Hemmatzadeh, Arezoo Gowhari Shabgah, Jamshid Gholizadeh Navashenaq, Saeed Aslani, Navid Shomali, Mohsen Arabi, Farhad Babaie, Farhad Jadidi-Niaragh, Ramin Hosseinzadeh, Fahimeh Feizisani, Sara Khodayar, Roghaiyeh Safari, Hamed Mohammadi |
| 71 |
[GO] |
2022―Okt―29 |
Retinoic acid-inducible gene 1 (RIG-1) and IFN-β promoter stimulator-1 (IPS-1) significantly down-regulated in the severe coronavirus disease 2019 (COVID-19) |
Peyman Nahavandi-Parizi, Ashraf Kariminik, Maryam Montazeri |
| 72 |
[GO] |
2022―Sep―22 |
Lectins from plant and algae act as anti-viral against HIV, influenza and coronaviruses |
Sanjay Naik, Sanjit Kumar |
| 73 |
[GO] |
2022―Sep―12 |
Non-coding RNA in idiopathic interstitial pneumonia and Covid-19 pulmonary fibrosis |
Mohammad Shadab Ali, Jay Singh, Md Tanjim Alam, Anita Chopra, Sudheer Arava, Ashu Seith Bhalla, Saurabh Mittal, Anant Mohan, Dipendra K Mitra, Vijay Hadda |
| 74 |
[GO] |
2022―Sep―12 |
Nitazoxanide and COVID-19: A review |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Engy Elekhnawy, Gaber El-Saber Batiha |
| 75 |
[GO] |
2022―Jul―09 |
Potential autonomic nervous system dysfunction in COVID-19 patients detected by heart rate variability is a sign of SARS-CoV-2 neurotropic features |
Maryame Mohammadian, Ravieh Golchoobian |
| 76 |
[GO] |
2022―Jul―07 |
Preliminary investigation of gene expression levels of PAPP-A, STC-2, and HIF-1α in SARS-Cov-2 infected patients |
Sevgi Karabulut Uzunçakmak, Muhammet Emin Naldan, Ebubekir Dirican, Ferhan Kerget, Zekai Halıcı |
| 77 |
[GO] |
2022―Jul―06 |
An outlook on potential protein targets of COVID-19 as a druggable site |
Rubia Noori, Meryam Sardar |
| 78 |
[GO] |
2022―Jun―26 |
SARS-CoV-2 cell entry beyond the ACE2 receptor |
Shamila D. Alipoor, Mehdi Mirsaeidi |
| 79 |
[GO] |
2022―Jun―13 |
Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq |
Peshnyar M. A. Rashid, Gaza F. Salih |
| 80 |
[GO] |
2022―Mai―24 |
Antimicrobial peptides: features, applications and the potential use against covid-19 |
Dalia Mamdouh Mabrouk |
| 81 |
[GO] |
2022―Mai―21 |
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases |
Devasahayam Arokiar Balaya Rex, Neelanchal Vaid, K. Deepak, Shobha Dagamajalu, T. S. Keshava Prasad |
| 82 |
[GO] |
2022―Mai―21 |
Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
Sneh Lata Gupta, Rishi K. Jaiswal |
| 83 |
[GO] |
2022―Mai―08 |
Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice |
Yanaysi Ceballo, Alina López, Carlos E. González, Osmany Ramos, Iván Andújar, Ricardo U. Martínez, Abel Hernández |
| 84 |
[GO] |
2022―Apr―20 |
Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics |
Huriye Erbak Yılmaz, Evin Iscan, Ozden Oz, Tuğçe Batur, Aybike Erdoğan, Seval Kılıç, Zeynep Mutlu, Murat Yılmaz, Kevin J. Spring |
| 85 |
[GO] |
2022―Apr―07 |
Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2 |
Ismail Celil Haskologlu, Emine Erdag, Serkan Sayiner, Nurettin Abacioglu, Ahmet Ozer Sehirli |
| 86 |
[GO] |
2022―Mrz―24 |
Factors associated with cycle threshold values (Ct-values) of SARS-CoV2-rRT-PCR |
Naila Shoaib, Naila Noureen, Arwa Faisal, Muhammad Zaheer, Muhammad Imran, Ali Ahsan, Rimsha Munir, Nousheen Zaidi |
| 87 |
[GO] |
2022―Mrz―17 |
Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results |
Aline de Souza Nicoletti, Marília Berlofa Visacri, Carla Regina da Silva Correa da Ronda, Pedro Eduardo do Nascimento Silva Vasconcelos, Julia Coelho França Quintanilha, Rafael Nogueira de Souza, Deise de Souza Ventura, Adriana Eguti, Lilian Ferreira de Souza Silva, Mauricio Wesley Perroud Junior, Rodrigo Ramos Catharino, Leonardo Oliveira Reis, Luiz Augusto dos Santos, Nelson Durán, Wagner José Fávaro, Marcelo Lancellotti, José Luiz da Costa, Patricia Moriel, Eder de Carvalho Pincinato |
| 88 |
[GO] |
2022―Mrz―06 |
Association of severity and mortality of Covid-19 cases among acute kidney injury and sexual dimorphism |
Mukul Kumar Singh, Mayank Jain, Hari Shyam, Dinesh Kumar Sahu, Archana Mishra, Pratap Shankar, Shailendra Kumar, Vishwajeet Singh |
| 89 |
[GO] |
2022―Mrz―02 |
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms |
Ameneh Jafari, Fahima Danesh Pouya, Zahra Niknam, Meghdad Abdollahpour-Alitappeh, Mostafa Rezaei-Tavirani, Yousef Rasmi |
| 90 |
[GO] |
2022―Feb―15 |
Ameliorating effects of probiotics on alterations in iron homeostasis and inflammation in COVID-19 |
Eman M. El-Sayed, Khadiga S. Ibrahim |
| 91 |
[GO] |
2022―Feb―02 |
Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients |
P. Monika, M. N. Chandraprabha |
| 92 |
[GO] |
2022―Jan―31 |
Modified uvsY by N-terminal hexahistidine tag addition enhances efficiency of recombinase polymerase amplification to detect SARS-CoV-2 DNA |
Kevin Maafu Juma, Teisuke Takita, Masaya Yamagata, Mika Ishitani, Kaichi Hayashi, Kenji Kojima, Koichiro Suzuki, Yuri Ando, Wakao Fukuda, Shinsuke Fujiwara, Yukiko Nakura, Itaru Yanagihara, Kiyoshi Yasukawa |
| 93 |
[GO] |
2022―Jan―31 |
Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study |
Diala Alhaj Moustafa, Zainab Imran, Roua Ismail, Menatallah Rayan, Alain-Pierre Gadeau, Hussein Eldassouki, Nabeel Abdulrahman, Fatima Mraiche |
| 94 |
[GO] |
2022―Jan―25 |
Blocking TNF signaling may save lives in COVID-19 infection |
Vitaly Ablamunits, Christopher Lepsy |
| 95 |
[GO] |
2022―Jan―24 |
The COVID-19-diabetes mellitus molecular tetrahedron |
Mehdi Mahmudpour, Katayoun Vahdat, Mohsen Keshavarz, Iraj Nabipour |
| 96 |
[GO] |
2022―Jan―22 |
Resolving the equation between mucormycosis and COVID-19 disease |
Ritu Pasrija, Mohammad Naime |
| 97 |
[GO] |
2022―Jan―14 |
Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients |
Mahtab Shahriari-Felordi, Hani Keshavarz Alikhani, Seyed-Mohammad Reza Hashemian, Moustapha Hassan, Massoud Vosough |
| 98 |
[GO] |
2022―Jan―06 |
Neutralizing antibody: a savior in the Covid-19 disease |
Sneh Lata Gupta, Rishi Kumar Jaiswal |
| 99 |
[GO] |
2022―Jan―02 |
Correction to: A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR |
Fadi Abdel Sater, Mahmoud Younes, Hassan Nassar, Paul Nguewa, Kassem Hamze |
| 100 |
[GO] |
2021―Nov―27 |
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection |
Antonio Vitiello, Francesco Ferrara |
| 101 |
[GO] |
2021―Nov―09 |
Bioprospecting of microalgae metabolites against cytokine storm syndrome during COVID-19 |
Che Lah Wan Afifudeen, Kit Yinn Teh, Thye San Cha |
| 102 |
[GO] |
2021―Okt―28 |
COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression |
Tahani Tabassum, Yusha Araf, Abu Tayab Moin, Tanjim Ishraq Rahaman, Mohammad Jakir Hosen |
| 103 |
[GO] |
2021―Okt―19 |
Niclosamide for Covid-19: bridging the gap |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Khalid J. Alzahrani, Athanasios Alexiou, Gaber El-Saber Batiha |
| 104 |
[GO] |
2021―Okt―16 |
The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword |
Mohammad Heydarian, Mohammadjavad Mohammadtaghizadeh, Mahboobeh Shojaei, Marziyeh Babazadeh, Sadegh Abbasian, Mehran Amrovani |
| 105 |
[GO] |
2021―Okt―15 |
Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19 |
Azadeh Manayi, Seyed Mohammad Nabavi, Maryam Khayatkashani, Solomon Habtemariam, Hamid Reza Khayat Kashani |
| 106 |
[GO] |
2021―Okt―14 |
The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization |
Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, Tayebeh latifi |
| 107 |
[GO] |
2021―Okt―13 |
Corticosteroids for COVID-19: worth it or not? |
Fariya Akter, Yusha Araf, Mohammad Jakir Hosen |
| 108 |
[GO] |
2021―Okt―07 |
A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR |
Fadil Abdel Sater, Mahmoud Younes, Hassan Nassar, Paul Nguewa, Kassem Hamze |
| 109 |
[GO] |
2021―Sep―12 |
Regenerated silica-based RNA purification columns to address the short supply of RNA purification kits for COVID-19 diagnosis |
Jitendra K. Biswal, Rajeev Ranjan, Shyam Singh Dahiya, Smrutirekha Mallick, Jajati K. Mohapatra |
| 110 |
[GO] |
2021―Aug―16 |
Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches |
Hany E. Marei, Asmaa Althani, Nahla Afifi, Giacomo Pozzoli, Thomas Caceci, Franco Angelini, Carlo Cenciarelli |
| 111 |
[GO] |
2021―Aug―15 |
How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels? |
Maryam Noori, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Kristin Carson-Chahhoud, Mohammadreza Ardalan, Ali-Asghar Kolahi, Saeid Safiri |
| 112 |
[GO] |
2021―Aug―12 |
Genomic evolution of the human and animal coronavirus diseases |
Carla Miranda, Vanessa Silva, Gilberto Igrejas, Patrícia Poeta |
| 113 |
[GO] |
2021―Jul―22 |
Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection |
K. A. Dvornikova, E. Yu. Bystrova, L. P. Churilov, A. Lerner |
| 114 |
[GO] |
2021―Mai―22 |
Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges |
Ismail Sami Mahmoud, Yazun Bashir Jarrar |
| 115 |
[GO] |
2021―Mai―03 |
miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as nteresting aspects for COVID-19 treatment and immunity |
Saber Soltani, Milad Zandi |
| 116 |
[GO] |
2021―Apr―23 |
Silent hypoxia in COVID-19: pathomechanism and possible management strategy |
Ahsab Rahman, Tahani Tabassum, Yusha Araf, Abdullah Al Nahid, Md. Asad Ullah, Mohammad Jakir Hosen |
| 117 |
[GO] |
2021―Apr―10 |
COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies |
Habib Haybar, Mahmood Maniati, Najmaldin Saki, Zeinab Deris Zayeri |
| 118 |
[GO] |
2021―Feb―23 |
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review |
Maria Elisabetta Onori, Claudio Ricciardi Tenore, Andrea Urbani, Angelo Minucci |
| 119 |
[GO] |
2021―Jan―23 |
SARS-COV-2 infection and lung tumor microenvironment |
Naila Malkani, Muhammad Usman Rashid |
| 120 |
[GO] |
2021―Jan―22 |
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19 |
Xingjuan Shi, Mengying Chen, Yu Zhang |
| 121 |
[GO] |
2020―Dez―12 |
BRCA testing delay during the COVID-19 pandemic: How to act? |
Angelo Minucci, Giovanni Scambia, Maria De Bonis, Elisa De Paolis, Concetta Santonocito, Anna Fagotti, Ettore Capoluongo, Paola Concolino, Andrea Urbani |
| 122 |
[GO] |
2020―Nov―13 |
Potential approaches to combat COVID-19: a mini-review |
Zainab Sarwar, Tahir Ahmad, Salik Kakar |
| 123 |
[GO] |
2020―Okt―26 |
A comparative phylogenomic analysis of SARS-CoV-2 strains reported from non-human mammalian species and environmental samples |
Aziz Ul-Rahman, Muhammad Abu Bakr Shabbir, Muhammad Waqar Aziz, Saima Yaqub, Asif Mehmood, Muhammad Asif Raza, Muhammad Zubair Shabbir |
| 124 |
[GO] |
2020―Okt―06 |
Recent advances in the nucleic acid-based diagnostic tool for coronavirus |
Pranav Kumar Prabhakar, Jyoti Lakhanpal |
| 125 |
[GO] |
2020―Sep―12 |
Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2 |
Simone Meini, Tommaso Giani, Carlo Tascini |
| 126 |
[GO] |
2020―Sep―12 |
Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147) |
Ahmet Ozer Sehirli, Serkan Sayiner, Nedime Serakinci |
| 127 |
[GO] |
2020―Jun―29 |
A contemporary review on pathogenesis and immunity of COVID-19 infection |
Rasoul Mirzaei, Sajad Karampoor, Mohammad Sholeh, Pouya Moradi, Reza Ranjbar, Faezeh Ghasemi |
| 128 |
[GO] |
2020―Mai―14 |
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19 |
Jiewen Fu, Baixu Zhou, Lianmei Zhang, Kyathegowdanadoddi Srinivasa Balaji, Chunli Wei, Xiaoyan Liu, Hanchun Chen, Jiangzhou Peng, Junjiang Fu |
| 129 |
[GO] |
2020―Mai―09 |
BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic |
Angelo Minucci, Giovanni Scambia, Concetta Santonocito, Paola Concolino, Andrea Urbani |
